Sumitomo Dainippon Pharma Co Ltd - Cost of Goods Sold Including Depreciation and Amortization

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Cost-of-Goods-Sold-Including-Depreciation-and-Amortization" stands at 162.60 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 09/30/2023.

Sumitomo Dainippon Pharma Co Ltd's first quarter result of 44.11 Billion JPY for the item "Cost of Goods Sold Including Depreciation and Amortization" represents an increase of 11.19 percent compared to it's fourth quarter result of the company's last fiscal year.

Also, Sumitomo Dainippon Pharma Co Ltd's first quarter result of 44.11 Billion JPY for the item "Cost of Goods Sold Including Depreciation and Amortization" represents an increase of 26.22 percent compared to it's first quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's first quarter result of 162.60 Billion JPY for the item "Cost of Goods Sold Including Depreciation and Amortization" represents an increase of 5.97 percent compared to it's fourth quarter result of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 24.03 percent compared to the value the year prior.
The 1 year change in percent is 24.03.
The 3 year change in percent is -1.28.
The 5 year change in percent is 18.96.
The 10 year change in percent is 57.12.

The Serie's long term average value is 122.22 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 33.03 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2012, to it's latest available value, on 06/30/2025, is +65.45%.
The Serie's change in percent from it's maximum value, on 12/31/2022, to it's latest available value, on 06/30/2025, is -9.19%.